i dont know if this is old news or new:
No date on it, except on bottom where it states 2008 copyrighted
Zynex Medical Announces HealthCanada Approval
Zynex Medical Holdings, Inc. today announced the approval of its NeuroMove™ stroke rehabilitation device by HealthCanada, the official health agency of the government of Canada. As a result of the review, HealthCanada approved the NeuroMove™ for sale throughout Canada. Our Canadian distributor, Biomation of Ontario, was instrumental in assisting Zynex to obtain this important approval license.
Zynex expects to have its other electrotherapy products, such as the IF8000, TruWave and E-wave approved by HealthCanada later this year or early next year.
Thomas Sandgaard, President and CEO said: "We are pleased to obtain this important approval by HealthCanada, opening another international market to our unique stroke recovery and rehabilitation device. This represents a continuation of our company's program to broaden and penetrate new international markets for our lines of electrotherapy devices. We intend to pursue this distribution route to the fullest possible extent."
ABOUT ZYNEX MEDICAL, INC.:
Zynex, a leading provider of therapeutic devices for patients with functional disability through the creation, distribution, and marketing of electrotherapy devices since 1996, strives to uphold its mission to improve the quality of life of patients suffering from debilitating pain or illness by providing innovative technology. Utilizing a unique combination of electromyographic (EMG) technology combined with a system of instruction and reinforcement, including electrical muscle stimulation (EMS), Zynex offers new treatment options to post-stroke and spinal injury patients.
"Safe Harbor" Statement: Certain statements in this release are "forward-looking" and as such are subject to numerous risks and uncertainties. Actual results may vary significantly from the results expressed or implied in such statements. Factors that could cause actual results to materially differ from forward-looking statements include, but are not limited to, the Company's ability to meet terms and conditions required to obtain project financing, risks and delays associated with product development, risk of market acceptance of new products, technology or product obsolescence, competitive risks, reliance on development partners, and additional capital needs.
--------------------------------------------------------------------------------
Copyright © 2008, MarketWire
Copyright © 2008, NewsBlaze, Daily News
Tags: Healthcare, Health, , Biotechnology, Pharmaceuticals, colorado
_ _
